AI Science Tracker
EN

The Fourth Affiliated Hospital of Zhejiang University Medical College

1 discovery from 2023

Discoveries

A fast and non-invasive artificial intelligence olfactory-like system that aids diagnosis of Parkinson's disease

Source check: Source checked. Not independent scientific confirmation.

Finding: Three learned classifiers were evaluated on sebum VOC data from Parkinson’s patients and controls; the best separated these groups but did not predict disease progression. Clinical diagnoses under UK Brain Bank criteria and matched controls provide the reference; held-out test split and repeated sensor runs are reported. Authors disclose no GC-MS verification of identities, possible medication/sample-volume confounding, and need for larger rigorous studies; no severity result.

Technology: GBDT, random forest and XGBoost classifiers operate on measured skin-sebum VOC time-series to distinguish clinically diagnosed PD from matched healthy controls; this is the enabled diagnostic result.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
GBDT, random forest and XGBoost classifiers operate on measured skin-sebum VOC time-series to distinguish clinically diagnosed PD from matched healthy controls; this is the enabled diagnostic result.
Test and result
Methods report 121 PD and 129 controls split 80:20 (200 train, 50 test); held-out GBDT sensitivity 83.33%, specificity 84%, AUC 0.893. Severity prediction failed, so scope is cross-sectional case-control discrimination.
Limitation / still unknown
Clinical diagnoses under UK Brain Bank criteria and matched controls provide the reference; held-out test split and repeated sensor runs are reported. Authors disclose no GC-MS verification of identities, possible medication/sample-volume confounding, and need for larger rigorous studies; no severity result. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://onlinelibrary.wiley.com/doi/10.1111/ene.16167 · https://pubmed.ncbi.nlm.nih.gov/38009830/ · https://pubmed.ncbi.nlm.nih.gov/35155895/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.